Implementation of Screen, Treat, and Triage for Women Living With HIV in La Romana (iSTAR)
Columbia University
600 participants
Feb 23, 2026
INTERVENTIONAL
Conditions
Summary
This study aims to conduct a randomized controlled trial to evaluate the effectiveness of same-day HPV-based screen and treat among women living with HIV (WLH) in La Romana, Dominican Republic. With cervical cancer being a leading cause of cancer-related deaths in women living with HIV, and cervical cancer deaths being preventable through screening and early detection, this project seeks to identify factors associated with the successful implementation of the Screen, Triage, and Treat approach to inform future implementation and scale-up.
Eligibility
Inclusion Criteria11
- years of age;
- female sex assigned at birth (any gender identity);
- HIV-positive;
- women who have had cervical cancer precursor lesions which were removed more than 6 months ago; and
- understand Spanish
- women who are pregnant, less than 6 weeks postpartum, or in whom pregnancy cannot be excluded;
- history of a Loop Electrosurgical Excision Procedure (LEEP) procedure in the last 6 months;
- history of a hysterectomy;
- previous diagnosis of gynecological cancer;
- history of cancer of the anogenital tract; or
- unable or unwilling to provide informed consent
Interventions
A screening test is used to determine who is eligible for treatment, eliminating steps related to histological confirmation. Those who meet the HPV criteria will be immediately evaluated for suitability for on-site ablative treatment on the same day. Women not suitable for treatment will be referred for colposcopy and further management at the appropriate facility.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07225530